A vast agreement to give access to Merck's anti-Covid to 105 poor countries

Broad agreement to provide access to Merck’s anti-Covid at home


Several dozen generic drug makers signed an agreement on Thursday with the Medicines Patent Pool (MPP) that is to give 105 low- and middle-income countries access to the group's anti-Covid pill pharmaceutical company Merck, according to a statement from the UN-backed agency.

The contract signed with 27 companies around the world follows the voluntary license agreement signed with Merck in October 2021 to facilitate global access at an affordable price to molnupiravir, the experimental oral antiviral drug against Covid-19, developed by the American pharmaceutical group, specifies MPP in its press release.


Share Button